For marketing, product, and publishing managers in the pharmaceutical industry
- We create innovative online and offline print publishing solutions to ensure incremental reach
- Use our interactive and experimental products to develop a dialogue with healthcare professionals
We will help to shape a campaign that goes straight to your target
- With our experience in medical publishing, Elsevier can act as your strategic media partner in optimizing your reach and budget
- We can help you to frame your message in the most credible and relevant context
- Associate your advertising message with a well respected, peer reviewed publication
We can help you to maximize your contribution to a conference
- We have many years of experience in the publication of congress materials which are an ideal method for rapid and powerful dissemination of your conference material or scientific findings
- Increase brand awareness with onsite & pre-event conference exposure
- Support and engage conference participants
Journals & Platforms
We Publish over 450 Health Science Journals including some of the most influential in the field:
-
Pain
-
The Lancet
-
Journal of Hepatology
-
Gastroenterology
-
Healthcare Management Forum
-
International Journal of Infectious Diseases
-
The Lancet Infectious Diseases
-
Disability and Health Journal
-
The American Journal of Medicine
-
The Journal Of Hospital Infection
SciVerse- ScienceDirect
OncologyStat
Health Advance
TheLancet.com
Recent Clinical Trials
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Bhupendra Khatri, et al. The Lancet Neurology, Volume 10, Issue 6, June 2011, Pages 520-529.
- Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Klemens Budde et al. The Lancet Neurology, Volume 10, Issue 6, June 2011, Pages 520-529.
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Javier Cortes, et al. The Lancet, Volume 377, Issue 9769, 12 March 2011-18 March 2011, Pages 914-923.
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.Luca Gianni, et al. The Lancet, Volume 377, Issue 9769, 12 March 2011-18 March 2011, Pages 914-923.
- Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial.Giuseppe Patti, et al. The American Journal of Cardiology, In Press, Corrected Proof, Available online 27 April 2011.
- Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.Diamant et al. The Lancet, Volume 375, Issue 9733, 26 June 2010-2 July 2010, Pages 2234-2243.
Conference Tools
We can help you organise and add value to your conference with the following tools and services:
MED Select
Content Direct
Abstracts on CD-Rom, USB or on the Web
CD-Rom Portal
Printing on Demand
Recent News
Forthcoming opportunities and events:
UK Neuromuscular Translational Research Conference 2012
The fifth joint annual meeting of the MRC Centre for Neuromuscular Diseases and the Muscular Dystrophy Campaign will take place on Thursday 22nd - Friday 23rd March 2012 at the Centre for Life, Newcastle upon Tyne. Read More
The EAU Congress 2012
For the third time in the nearly 30 years of the EAU Annual Congress, we return to Paris. The 27th Annual EAU Congress will be held on 24 February - 28 February 2012. Read More
The World Diabetes Congress 2012, Dubai
The International Diabetes Federation and its member associations have been effective in raising awareness of and providing the evidence on diabetes. The Federation’s Diabetes Atlas is a respected source of diabetes statistics and World Diabetes Day is celebrated throughout the world. Our World Diabetes Congress brings together more than 15,000 diabetes advocates every two years. Read More
Sign Up For Our Free Webinar
Whilst we are world-renowned for an impressive collection of scientific journals, we are also pioneers in electronic publishing and digital media solutions in the medical and scientific world. With Elsevier as multi-media partner, you have access to unrivalled reach in your choice of communication vehicles targeting healthcare professionals on a global level.
Read More
Sign up now for:
- Quarterly newsletter and product alerts
- Pharma marketing intelligence
- Free access to webinars and workshops
Conference Calendar
Find us at the following Conferences:
International AIDS Society Meeting
July 17 2011 Rome
Visit the Conference Website